Problem statement: Answer the MCQ question.
Query: Which drug exhibits a -23.126% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
[a] CCC(=NC(C)c1ccccc1)c1c(O)[nH]c(=O)[nH]c1=O
[b] Cc1ccc(-c2csc(NC(=O)c3ccccc3Cl)c2C(=O)O)cc1
[c] COc1ccc(NC(=O)C(CC(C)C)NC(=O)C2CCCCC2)c(OC)c1
[d] O=S(=O)(c1cccc(-c2cn3cc(Cl)ccc3n2)c1)N1CCOCC1
[e] Br.COc1ccc(-c2cn3c(n2)CCC3)cc1
Answer: d. O=S(=O)(c1cccc(-c2cn3cc(Cl)ccc3n2)c1)N1CCOCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=S(=O)(c1cccc(-c2cn3cc(Cl)ccc3n2)c1)N1CCOCC1
O=S(=O)(c1cccc(-c2cn3cc(Cl)ccc3n2)c1)N1CCOCC1
4-[3-(6-chloroimidazo[1,2-a]pyridin-2-yl)phenyl]sulfonylmorpholine